Sina C. Rosenkranz studied medicine at the Universities of Hamburg, Berlin, Zürich, Pretoria and Campeche and started her residency in 2012 at the Department of Neurology at the University Medical Centre Hamburg-Eppendorf by focusing on Neuroimmunology. After completing her MD thesis at the Institute of Neuropathology on Alzheimer‘s disease she enrolled in the MD/PhD programme of the UKE where she investigated the role of mitochondrial alterations during Multiple Sclerosis. Currently she is working on the molecular basis of neuroprotective behavioural interventions, such as exercise and hypoxia. She is one of four fellows of the Hertie Network of Excellence in Clinical Neuroscience.
Link to Pubmed